Every drug you've ever taken — every vaccine, every surgical technique, every cancer therapy — reached you because thousands of volunteers agreed to test it first. Clinical trials are how medicine moves forward. And yet most patients have never seriously considered joining one, often because no one has explained what they actually are.
This guide answers every fundamental question: what a clinical trial is, why they exist, how they're structured, what participating looks like, and how to find one for your condition.
About this article: This article is educational only. It does not constitute medical advice, eligibility guidance, or a recommendation to join any clinical trial. Always discuss clinical trial options with your physician before pursuing enrollment.
In This Article
- 1.The Simple Definition
- 2.Why Clinical Trials Exist
- 3.The Four Phases of Clinical Trials
- 4.Types of Clinical Trials
- 5.Who Can Join a Clinical Trial?
- 6.What Happens When You Join
- 7.Your Rights as a Participant
- 8.The Benefits and Risks
- 9.How to Find a Clinical Trial
- 10.Questions to Ask Before Enrolling
- 11.Frequently Asked Questions
The Simple Definition
A clinical trial is a research study in which human volunteers agree to test a medical intervention — typically a drug, device, procedure, or behavioral approach — under controlled conditions. The goal is to generate scientific evidence about whether the intervention is safe, effective, or better than current options.
Clinical trials are the only way to prove that a medical treatment works in human beings. Laboratory results, animal studies, and computer models can generate hypotheses — but they cannot replace evidence collected from actual patients.
Why Clinical Trials Exist
The modern clinical trial system was built in response to tragedies. In the 1950s, thalidomide — prescribed to pregnant women for morning sickness — caused severe birth defects in thousands of children before being withdrawn. The disaster exposed a fundamental gap: drugs were being approved without rigorous human evidence. The 1962 Kefauver-Harris Amendment to the U.S. Food, Drug, and Cosmetic Act overhauled FDA oversight and made well-controlled clinical trials mandatory for drug approval.
Today, clinical trials serve several overlapping purposes:
- Safety evaluation: Identify side effects, drug interactions, and dangerous doses before widespread patient exposure.
- Efficacy confirmation: Prove that a treatment actually works — not just that it looks promising in a test tube or animal model.
- Comparative effectiveness: Determine whether a new treatment is better, equivalent, or worse than existing options.
- Optimal use: Identify the best dose, duration, route of administration, and patient population for a given treatment.
- Prevention and early detection: Some trials test whether an intervention can prevent a disease from developing in high-risk individuals.
Without clinical trials, medicine cannot advance. Every drug you've taken was approved because it cleared this system. Every therapy your doctor can offer was tested in people who volunteered to be first.
The Four Phases of Clinical Trials
Clinical trials move through structured phases, each answering a different question before proceeding to the next. Understanding the phases helps you evaluate the risk and purpose of any trial you consider.
First-in-human testing. Small groups (20–100 people) receive the treatment at increasing doses. The goal is to identify side effects, find the maximum safe dose, and understand how the body processes the drug. In cancer trials, Phase 1 often enrolls patients who have exhausted other options. In non-cancer trials, healthy volunteers are common.
Larger groups (100–300) test whether the drug has a therapeutic effect in patients with the target condition. Researchers refine the optimal dose and look for early efficacy signals. Phase 2 is a "proof of concept" — promising but not yet definitive.
Large, randomized, controlled trials (300–3,000+ participants) compare the new treatment to current standard of care. Phase 3 trials generate the evidence used for FDA approval. These trials have more sites, broader eligibility criteria, and are more accessible to patients at community hospitals.
Conducted after FDA approval, Phase 4 studies monitor long-term safety in large populations, explore new indications, and compare effectiveness in real-world settings. The drug is already approved and commercially available.
For a complete breakdown of each phase — including what each means for participant risk, eligibility, and what you should ask — see our detailed guide: Phase 1, 2, 3, and 4 Clinical Trials: What Each Phase Means for Patients.
Types of Clinical Trials
Not all clinical trials test new drugs. The term "clinical trial" covers a range of research designs:
Treatment trials
The most common type. These test new drugs, biologics, gene therapies, devices, surgical procedures, or combinations. When most people think of "a clinical trial," this is what they mean.
Prevention trials
Test approaches to prevent a disease from developing in people who have not yet had it — or to prevent recurrence in people who have. Examples include cancer prevention trials testing chemoprevention drugs in high-risk individuals, and vaccine trials.
Observational studies
Participants are observed over time without receiving an experimental intervention. The goal is to understand disease natural history, identify risk factors, or validate biomarkers. The famous Nurses' Health Study and Framingham Heart Study are observational research. No investigational drug is provided — but participation generates data that guides future trials.
Diagnostic trials
Test new ways to detect a disease earlier or more accurately — including imaging techniques, blood tests, and biomarker assays.
Quality of life / supportive care trials
Study ways to improve comfort, reduce side effects, and improve quality of life for patients managing a chronic disease or undergoing treatment. These often involve behavioral interventions, palliative care approaches, or symptom management strategies.
Expanded access (compassionate use)
Not a trial in the traditional sense — this pathway allows patients with serious or life-threatening conditions to access an investigational drug outside of a clinical trial when no comparable alternatives exist.
Who Can Join a Clinical Trial?
Every clinical trial has eligibility criteria — a list of characteristics that define who can and cannot participate. These are divided into two types:
- Inclusion criteria: Characteristics you must have to qualify. Examples: a specific diagnosis, age range, disease severity score, or biomarker status.
- Exclusion criteria: Characteristics that disqualify you. Examples: certain other medical conditions, prior treatments, current medications, or recent surgeries.
Eligibility criteria exist for two reasons: scientific validity (a homogeneous patient population produces cleaner data) and participant safety (some treatments are not safe in patients with certain conditions). Being excluded from one trial does not mean you are excluded from all trials — different studies have different criteria.
What if you don't meet the criteria? Eligibility criteria are strict, but they vary widely between trials testing the same condition. A patient excluded from one trial for "prior biologic failure" may be the ideal candidate for the next trial that specifically requires prior biologic failure. Search broadly, and always contact the research coordinator to ask — some criteria have exceptions or protocol amendments that aren't obvious from the listing.
What Happens When You Join a Clinical Trial
Step 1: Screening
Before you can officially enroll, you go through a screening period. The research team reviews your medical history, conducts physical exams, orders blood work, and may require imaging or biopsies to confirm you meet eligibility criteria. Screening can take days to weeks. Failing a screening criterion does not mean the study was wrong for you — it means the biology or timing didn't fit that particular protocol.
Step 2: Informed consent
Before anything happens, you must review and sign an informed consent document. This is not a waiver — it's a disclosure. The document must explain the purpose of the trial, all known risks and benefits, what procedures are involved, how your data will be used, and your right to withdraw at any time. You have the right to ask questions, take time to decide, and have a family member or advocate present. Signing does not lock you in.
Step 3: Randomization (if applicable)
In randomized trials, you are assigned to a treatment group by chance — not by choice or physician judgment. You may receive the experimental treatment, a comparator (standard of care), or, in some trials, a placebo. In blinded trials, you won't know which group you're in until the trial ends.
Step 4: Treatment and visits
You receive the assigned intervention and attend scheduled visits. Visits involve check-ins, blood draws, physical exams, and assessments of how you're responding. The frequency varies — from weekly visits early in a trial to monthly or quarterly visits in long-term studies. Some modern decentralized trials allow home nursing visits or remote monitoring, reducing the travel burden significantly.
Step 5: Follow-up
After the treatment period ends, most trials include a follow-up period to assess long-term safety and durability of response. This may last months to years. Some trials offer open-label extension studies — where responders can continue the drug outside the randomized period.
Your Rights as a Participant
Clinical trial participants have federally protected rights, enforced through FDA regulations, Institutional Review Board (IRB) oversight, and the Declaration of Helsinki:
Full disclosure
You must be told everything known about the treatment, including all identified risks and uncertainties, before consent.
Voluntary participation
Participation is always voluntary. You can withdraw at any time, for any reason, without penalty or loss of medical care.
Privacy protection
Your personal and medical information is protected under HIPAA. Published trial results use de-identified data.
Ongoing safety information
If new safety information emerges during the trial, you must be informed — even if it means re-consenting.
Access to standard care
Participation in a trial cannot be used to deny you access to standard medical care for your condition.
Free treatment
The investigational drug and all study-related procedures are provided at no cost to you. Some routine care costs may still fall to your insurer.
The Benefits and Risks
Potential benefits
- Access to new treatments not yet commercially available
- Close monitoring by a specialized research team
- No cost for the investigational drug and study-related care
- Compensation for time and travel in many trials
- Contributing to research that may help future patients
- Access to academic medical centers and expertise through trial sites
Potential risks
- Unknown or understudied side effects
- Randomization to a comparator or placebo arm (not the experimental drug)
- Time commitment: frequent visits, blood draws, and assessments
- Travel requirements to trial sites
- The treatment may not work for you specifically
- The trial may be stopped early if safety issues arise
The risk-benefit calculus shifts by phase and disease. For a patient with advanced cancer who has no remaining standard options, the potential benefit of a Phase 1 trial may far outweigh the risks. For a patient with well-controlled mild psoriasis, the calculus is very different. Talk to your doctor about where you are in your treatment journey before evaluating trial options.
How to Find a Clinical Trial
There are several ways to search for clinical trials. The most important starting points:
ClinicalTrials.gov
The official U.S. registry maintained by the National Library of Medicine (NLM), part of NIH. Every trial testing a drug or device in the U.S. is required to register here. As of 2025, the registry contains over 500,000 studies. The search interface is powerful but dense — most patients find it overwhelming.
Tidera Health
Tidera searches ClinicalTrials.gov in real time and adds an AI-powered layer: match scores, plain-English eligibility summaries, and questions to ask the research coordinator. It's free and requires no account. You can search by condition, location, age, sex, and treatment history.
Disease-specific registries
Patient advocacy organizations often maintain their own trial listings. The Alzheimer's Association's Trial Match, the MS Society's research page, the Crohn's & Colitis Foundation's trial finder, and similar tools curate trials relevant to their communities.
Your specialist
Academic oncologists, rheumatologists, neurologists, and other specialists often know about relevant open trials through professional networks, site affiliations, or industry relationships. Ask directly: "Are there any clinical trials I should know about for my condition?"
Search recruiting trials for your condition
Tidera searches ClinicalTrials.gov in real time — matched to your condition, location, and treatment history. Free, no account required.
Questions to Ask Before Enrolling
Before signing an informed consent document, these are the questions every patient should have answered:
About the treatment
- →What exactly is being tested?
- →What phase is this trial?
- →What is the comparator arm — placebo, standard of care, or another drug?
- →What is the expected benefit based on Phase 1/2 data?
About the risks
- →What are the known side effects at this dose?
- →What happened to participants in the earlier phase trials?
- →How will adverse events be monitored and managed?
- →Is there a Data Safety Monitoring Board reviewing the trial?
About logistics
- →How often do I need to come in for visits?
- →How long is the trial?
- →Is travel reimbursement provided?
- →What happens if I need to withdraw?
About your ongoing care
- →Can I continue my current medications?
- →What happens to my standard care during the trial?
- →If the trial ends early, what are my options?
For a complete checklist of 20 questions, see our guide: 20 Questions to Ask Before Joining a Clinical Trial.
Frequently Asked Questions
Are clinical trials only for people who have no other options?
No — this is one of the most persistent myths about clinical trials. Many trials enroll patients at all stages: newly diagnosed patients, patients who are well-controlled on standard therapy, patients who have failed one prior treatment, and patients with advanced disease. Healthy volunteer trials specifically require people without any diagnosed condition. The right trial depends on where you are in your treatment journey, not whether you've "run out of options."
Will I definitely receive the experimental treatment?
Not necessarily. In randomized controlled trials, you are assigned to a group by chance — you may receive the experimental drug, a comparator (often the current standard of care), or in some cases a placebo. Before enrolling, always ask: "What are the arms of this trial and what is the probability of receiving the experimental drug?" In many trials, the comparator is not placebo but active standard of care, so both arms offer a meaningful treatment.
Does joining a clinical trial cost money?
The investigational drug and all study-related procedures (blood tests, imaging, study visits) are provided at no cost by the trial sponsor. However, your insurer may still be responsible for "routine care costs" — your regular medical care that would have happened regardless of trial participation. The Affordable Care Act requires most insurers to cover routine care costs for patients in approved clinical trials. Ask your insurer and the research team about specific coverage.
Can I leave a clinical trial after I've started?
Yes, always. Participation is voluntary and you can withdraw at any time for any reason — without penalty, without losing access to your medical care, and without any obligation to explain your decision. The only thing you cannot do is retroactively withdraw data that has already been included in published analyses, though you can request removal of future use of your data.
How do clinical trials get approved?
Every clinical trial involving an unapproved drug must file an Investigational New Drug (IND) application with the FDA before human testing begins. Additionally, every trial must be reviewed and approved by an Institutional Review Board (IRB) — an independent ethics committee that evaluates whether the risk-benefit profile is acceptable, whether the informed consent process is adequate, and whether participant protections are in place. The IRB reviews ongoing trials at least annually.
What is a placebo and when is it ethical to use one?
A placebo is an inert treatment designed to look identical to the active drug, used in blinded trials so neither participants nor researchers know who received what. Placebo controls are scientifically valuable because they distinguish drug effects from the natural course of disease and psychological expectation (the "placebo effect"). However, when an effective treatment already exists, ethics require that the comparator arm receive active standard of care — not a placebo. Placebo-only controls are acceptable when no proven treatment exists for the condition or when the placebo is added on top of standard background therapy.
Related Articles